Resona Asset Management Co. Ltd. Sells 7,595 Shares of Sabra Healthcare REIT, Inc. $SBRA

Resona Asset Management Co. Ltd. trimmed its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 7.4% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 95,165 shares of the real estate investment trust’s stock after selling 7,595 shares during the quarter. Resona Asset Management Co. Ltd.’s holdings in Sabra Healthcare REIT were worth $1,739,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. SVB Wealth LLC acquired a new stake in shares of Sabra Healthcare REIT in the first quarter worth about $34,000. Wealth Preservation Advisors LLC acquired a new stake in Sabra Healthcare REIT in the 1st quarter worth approximately $38,000. Northwestern Mutual Wealth Management Co. boosted its position in Sabra Healthcare REIT by 61.2% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust’s stock worth $49,000 after purchasing an additional 1,065 shares during the period. Anchor Investment Management LLC bought a new stake in Sabra Healthcare REIT during the first quarter worth approximately $58,000. Finally, Assetmark Inc. grew its holdings in Sabra Healthcare REIT by 37.8% during the first quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust’s stock valued at $63,000 after purchasing an additional 989 shares during the last quarter. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Trading Up 1.1%

Shares of SBRA stock opened at $19.08 on Tuesday. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $20.03. The firm’s fifty day simple moving average is $18.40 and its 200 day simple moving average is $18.28. The firm has a market capitalization of $4.76 billion, a P/E ratio of 25.11, a price-to-earnings-growth ratio of 1.10 and a beta of 0.84.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.01. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The company had revenue of $190.04 million for the quarter, compared to analyst estimates of $193.44 million. During the same period last year, the business posted $0.37 EPS. The business’s quarterly revenue was up 6.7% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. As a group, sell-side analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 28th. Investors of record on Monday, November 17th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.3%. The ex-dividend date is Monday, November 17th. Sabra Healthcare REIT’s payout ratio is currently 166.67%.

Analysts Set New Price Targets

A number of analysts have recently weighed in on SBRA shares. BMO Capital Markets boosted their price objective on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a “market perform” rating in a research note on Monday, August 25th. National Bankshares set a $22.00 target price on shares of Sabra Healthcare REIT in a report on Friday, October 17th. JMP Securities boosted their target price on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a “market outperform” rating in a research report on Wednesday, August 6th. Truist Financial raised their price target on Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a “hold” rating in a research report on Tuesday, September 2nd. Finally, Wells Fargo & Company dropped their price objective on Sabra Healthcare REIT from $21.00 to $20.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $20.75.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.